All data are based on the daily closing price as of June 27, 2025
m
Microbio
4128.TWO
0.80 USD
-0.01
-1.23%
Overview
Last close
0.80 usd
Market cap
471.26M usd
52 week high
1.48 usd
52 week low
0.61 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
7.7732
Price/Book Value
1.4172
Enterprise Value
399.53M usd
EV/Revenue
6.5758
EV/EBITDA
-10.9139
Key financials
Revenue TTM
60.76M usd
Gross Profit TTM
23.82M usd
EBITDA TTM
-11.74M usd
Earnings per Share
-0.06 usd
Dividend
N/A usd
Total assets
397.90M usd
Net debt
N/A usd
About
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei City, Taiwan.